According to literature reports, related studies on mast-cell-derived FGF2 mainly focus on angiogenesis, fibrosis, wound healing, and diseases involving hypertensive renal damage, airway hyperresponsiveness, chronic obstructive pulmonary disease and other diseases (35, 37, 38, 61). This evidence concerns the gene FGF2 and chronic obstructive pulmonary disease.